IGFBP3 and breast cancer: Similarly, cases expressing IGFBP3 were at higher risk of all-cause and breast cancer mortality (HRmort = 5.16, 95% CI: 1.27–20.94 and HRmort = 8.60, 95% CI: 1.84–40.15), respectively).